News

[NEWS] – Biofortis obtains ANSM authorization and strengthens its position in the development of microbiota-derived therapies

Biofortis announces that it has obtained authorization from the French National Agency for the Safety of Medicines and Health Products (ANSM) for its activities involving the collection of human stool samples intended for the preparation of fecal microbiota for...

[EVENT] Biofortis, membre du comité d’organisation et Sponsor Silver de la Journée Nutrition & Microbiote 2025

16 octobre 2025, Nantes FRBiofortis participera à la Journée Nutrition & Microbiote, organisée par Atlanpôle Biothérapies, le 16 octobre 2025, en tant que membre du comité d’organisation, avec l’implication de Thomas Carton (Scientific Operations Manager), et...

[EVENT] – Biofortis and analyze & realize will be present at Vitafoods Europe 2025

May 20th/21st/22nd, 2025in Barcelona, SpainFor this 2025 edition, we will be present in the booth 3J136F on French Pavilion.   Vitafoods Europe is one of the most important events in the world’s nutraceutical. Each year, the event gathers thousands of attendees and...

[PRESS RELEASE] Biofortis and Teranga strengthen their service offerings with the acquisition of NEOVIX group 

A Strategic expansion to enhance services in Health & Wellness  Nantes, France – March 4, 2025 – We are pleased to announce our strategic partnership with TERANGA Group. With the acquisition of NEOVIX Group (including AR2i, Cosmetic Office, White Tillet, SCM...